Mobix Labs Form 4: 46,855 RSUs Granted; Vested Options Total 153,416 Shares
Rhea-AI Filing Summary
Kurt Busch, a director of Mobix Labs, Inc. (MOBX), reported awards and existing holdings on a Form 4 dated with transactions on 09/23/2025. The filing shows 46,855 restricted stock units (RSUs) were granted to Mr. Busch on 09/23/2025, increasing his beneficial ownership to 372,429 shares of Class A common stock.
The report also lists two fully vested, exercisable stock options held directly by Mr. Busch: an option to buy 20,000 shares at an exercise price of $4.18 (expiration 08/10/2030) and an option to buy 133,416 shares at $6.84 (expiration 04/04/2032). The Form 4 was signed by an attorney-in-fact, Terri Aprati, on 09/25/2025.
Positive
- 46,855 RSUs granted to the reporting director on 09/23/2025, as explicitly stated
- Beneficial ownership reported at 372,429 Class A common shares following the RSU grant
- Two option series are fully vested and exercisable, with documented exercise prices and expiration dates
Negative
- None.
Insights
TL;DR: Director received RSUs and holds fully vested options, increasing his reported beneficial stake to 372,429 shares.
The grant of 46,855 RSUs is a clear compensation event that raises the director's reported economic interest to 372,429 Class A shares. The filing also documents two option series totaling 153,416 underlying shares that are fully vested and exercisable, with exercise prices of $4.18 and $6.84 and expirations in 2030 and 2032 respectively. For investors, these figures clarify share-based compensation and the director's potential future exercising activity; the filing does not disclose cash proceeds or exercises occurring on the reported date.
TL;DR: Standard insider disclosure: RSU grant and vested options reported by a director, filed under Section 16.
The Form 4 fulfills Section 16 reporting requirements by documenting an RSU grant and existing option holdings by a director. The report identifies the reporting person, relationship to the issuer (director), the transaction date (09/23/2025), and signature by an attorney-in-fact. No amendments or corrective disclosures are indicated. This is a routine executive compensation and ownership disclosure rather than a governance dispute or compliance exception.